NASDAQ:RCEL Avita Medical (RCEL) Stock Price, News & Analysis $4.25 -1.13 (-21.00%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.27 +0.02 (+0.45%) As of 08/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Avita Medical Stock (NASDAQ:RCEL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Avita Medical alerts:Sign Up Key Stats Today's Range$3.60▼$4.2650-Day Range$4.25▼$6.2652-Week Range$3.60▼$14.16Volume1.73 million shsAverage Volume260,951 shsMarket Capitalization$112.33 millionP/E RatioN/ADividend YieldN/APrice Target$13.60Consensus RatingHold Company Overview AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California. Read More Avita Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreRCEL MarketRank™: Avita Medical scored higher than 23% of companies evaluated by MarketBeat, and ranked 822nd out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingAvita Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAvita Medical has only been the subject of 2 research reports in the past 90 days.Read more about Avita Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Avita Medical are expected to grow in the coming year, from ($0.95) to ($0.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avita Medical is -2.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avita Medical is -2.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvita Medical has a P/B Ratio of 25.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted23.26% of the float of Avita Medical has been sold short.Short Interest Ratio / Days to CoverAvita Medical has a short interest ratio ("days to cover") of 19.3, which indicates bearish sentiment.Change versus previous monthShort interest in Avita Medical has recently increased by 4.20%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvita Medical does not currently pay a dividend.Dividend GrowthAvita Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted23.26% of the float of Avita Medical has been sold short.Short Interest Ratio / Days to CoverAvita Medical has a short interest ratio ("days to cover") of 19.3, which indicates bearish sentiment.Change versus previous monthShort interest in Avita Medical has recently increased by 4.20%, indicating that investor sentiment is decreasing. News and Social Media2.2 / 5News Sentiment0.01 News SentimentAvita Medical has a news sentiment score of 0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Avita Medical this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for RCEL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Avita Medical to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Avita Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.80% of the stock of Avita Medical is held by insiders.Percentage Held by InstitutionsOnly 27.66% of the stock of Avita Medical is held by institutions.Read more about Avita Medical's insider trading history. Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avita Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address RCEL Stock News HeadlinesAVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call TranscriptAugust 8 at 4:06 PM | seekingalpha.comAvita Medical (RCEL) Q2 Sales Up 21%August 7 at 10:26 PM | fool.comElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.August 9 at 2:00 AM | Banyan Hill Publishing (Ad)AVITA Medical to Announce Second Quarter 2025 Financial ResultsJuly 28, 2025 | globenewswire.comAvita Medical Ltd (RCEL) Stock Forums - Investing.comJune 30, 2025 | investing.comAVITA Medical, Inc. (RCEL) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comAnalysts Expect Breakeven For AVITA Medical, Inc. (NASDAQ:RCEL) Before LongJune 21, 2025 | finance.yahoo.comAVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™June 5, 2025 | finance.yahoo.comSee More Headlines RCEL Stock Analysis - Frequently Asked Questions How have RCEL shares performed this year? Avita Medical's stock was trading at $12.80 at the beginning of 2025. Since then, RCEL shares have decreased by 66.8% and is now trading at $4.25. How were Avita Medical's earnings last quarter? Avita Medical Inc. (NASDAQ:RCEL) posted its quarterly earnings data on Thursday, August, 7th. The company reported ($0.38) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.12. The company had revenue of $18.42 million for the quarter, compared to the consensus estimate of $34.27 million. Avita Medical had a negative trailing twelve-month return on equity of 1,272.91% and a negative net margin of 68.87%. Read the conference call transcript. Who are Avita Medical's major shareholders? Top institutional shareholders of Avita Medical include Intech Investment Management LLC (0.04%). Insiders that own company stock include Michael S Perry, Robert Mcnamara, Donna Shiroma, Suzanne Crowe, Jeremy Curnock Cook and James Corbett. View institutional ownership trends. How do I buy shares of Avita Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avita Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avita Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA). Company Calendar Last Earnings8/07/2025Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:RCEL CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees130Year Founded2008Price Target and Rating Average Price Target for Avita Medical$13.60 High Price Target$21.00 Low Price Target$3.00 Potential Upside/Downside+220.0%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($2.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$61.85 million Net Margins-68.87% Pretax Margin-79.56% Return on Equity-1,272.91% Return on Assets-67.18% Debt Debt-to-Equity Ratio9.39 Current Ratio2.09 Quick Ratio1.72 Sales & Book Value Annual Sales$64.25 million Price / Sales1.75 Cash FlowN/A Price / Cash FlowN/A Book Value$0.17 per share Price / Book25.00Miscellaneous Outstanding Shares26,430,000Free Float25,695,000Market Cap$112.33 million OptionableOptionable Beta1.63 Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:RCEL) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avita Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avita Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.